DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award

US Department of the Army – U › S › Army Medical Research Acquisition Activity (USAMRAA) grant open #HT942526ALSRPTIA

Response due Sep 30, 2026 · 00:00 UTC

Summary

The U.S. Army Medical Research Acquisition Activity (USAMRAA) is soliciting applications for the Department of Defense Amyotrophic Lateral Sclerosis (ALS) Research Program under the Therapeutic Idea Award mechanism. This funding opportunity targets novel therapeutic concepts for ALS, a fatal neurodegenerative disease. The program is administered through Grants.gov as a federal grant/cooperative agreement and is open from May 2026 through September 2026. Specific research requirements, funding ceilings, and eligibility details would be contained in the full Program Announcement, which is not included in this synopsis.

What they want

Applicants are invited to submit research proposals under the DoD ALS Research Program's Therapeutic Idea Award mechanism. The award is intended to support innovative, high-impact therapeutic ideas related to Amyotrophic Lateral Sclerosis. The solicitation is issued by the Department of the Army – USAMRAA (U.S. Army Medical Research Acquisition Activity) under opportunity number HT942526ALSRPTIA. Full programmatic requirements, allowable costs, milestones, and deliverables are defined in the associated Program Announcement available on Grants.gov.

How they evaluate

Submission: Grants.gov electronic submission portal

Risks & flags

Extremely limited synopsis — no funding ceiling, no programmatic requirements, no eligibility criteria, and no evaluation criteria disclosed; full program announcement required to assess competitiveness.
Short opportunity number (HT942526ALSRPTIA) suggests a specific DoD program office vehicle that may have established incumbent research teams from prior ALS Research Program cycles.

Market context

inferred from NAICS

Professional, Scientific & Technical Services

NAICS 541714

US market size: $2.0T
Typical award: $25K – $50M

Typical buyers

All federal civilianDoDStates

Commonly required

8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

DoW Amyotrophic Lateral Sclerosis Research…

Due Sep 30

Onboard ↗